CHOLESTEROL AS A CLINICAL AND LABORATORY MARKER OF METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF DIFFERENT AGE GROUPS

Authors

DOI:

https://doi.org/10.11603/2414-4533.2024.3.14925

Keywords:

hypercholesterolemia, lipid metabolism, statins, WHO age classification, gender characteristics

Abstract

The aim of the work: to study the frequency of hypercholesterolemia and the use of statins in patients with coronary artery disease of different age groups, taking into account gender characteristics.

Materials and Methods. The study included patients with coronary heart disease who underwent coronary bypass surgery on a working heart (n=3674), both males (n=3061) and females (n=613), the average age of the study participants was 60.6±0.8 years. The material for the analysis was the data of a clinical laboratory study of biological fluid – blood. The research design is based on the patient's age group according to the age classification of the WHO and the patient's gender.

Results and Discussion. It was established that the highest cholesterol levels were in the "middle age" age group, both in men – 3.54 mmol/l, and in women – 3.89 mmol/l. It was found that the frequency of hypercholesterolemia was significantly higher in female patients compared to the corresponding frequency in men, p=0.0001, χ2=14.48. The highest frequency of hypercholesterolemia was observed in patients of the "middle age" age group, and in male patients its frequency was significantly lower than in female patients of the same age group, p=0.0001, χ2=18.08. It was established that with increasing age and taking into account the gender of the patients, there was a significant physiological decrease in the frequency of hypercholesterolemia. It was determined that statins were used significantly more often by female patients – 49.4%, compared to the corresponding frequency in male patients – 32.2 %, p=0.0001, χ2=73.89. It was also found that women with coronary heart disease were significantly more likely to use statins in all age groups compared to men.

Conclusions. As a result of the study, it was found that cholesterol levels remain a reliable clinical and laboratory marker for detecting metabolic disorders in patients with coronary artery disease. It was determined that the highest cholesterol levels were recorded in middle-aged patients of both sexes. Hypercholesterolemia is also significantly more common in the "middle-aged" age group, and taking into account gender, it is significantly more common in patients with coronary artery disease. It was determined that with age there is a significant decrease in the level of cholesterol, regardless of taking statins.

References

Motallaei M, Darand M, Taftian M, et al. A cross-sectional study on the association between lifestyle factors and coronary artery stenosis severity among adults living in central Iran: A protocol for the Iranian- CARDIO study. ARYA Atheroscler. 2024;20(1):51-61. DOI:10.48305/arya.2023.41026.2843.

Khan MA, Hashim MJ, Mustafa H, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12(7):e9349. Published 2020 Jul 23. doi:10.7759/cureus.9349.

Cardiovascular diseases. WHO report 2021; available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standar­dization of clinical nomenclature. Circulation. 2006;59(3): 607–9.

Adhikary D, Barman S, Ranjan R, Stone H. A Systematic Review of Major Cardiovascular Risk Factors: A Growing Glo­bal Health Concern. Cureus. 2022 Oct 10;14(10):e30119. DOI: 10.7759/cureus.30119. PMID: 36381818; PMCID: PMC9644238.

Guan C, Wu S, Xu W, Zhang J. Global, regional, and national burden of ischaemic heart disease and its trends, 1990-2019. Public Health. 2023;223:57-66. DOI:10.1016/j.puhe.2023.07.010.

Nunes VS, da Silva Ferreira G, Quintão ECR. Cholesterol metabolism in aging simultaneously altered in liver and nervous system. Aging (Albany NY). 2022 Feb 7;14(3):1549-1561. DOI: 10.18632/aging.203880. Epub 2022 Feb 7. PMID: 35130181; PMCID: PMC8876915.

Liu HH, Li JJ. Aging and dyslipidemia: a review of potential mechanisms. Ageing Res Rev. 2015;19:43-52. DOI:10.1016/j.arr.2014.12.001

Yandrapalli S, Gupta S, Andries G, Cooper HA, Aronow WS. Drug Therapy of Dyslipidemia in the Elderly. Drugs Aging. 2019;36(4):321-340. DOI:10.1007/s40266-018-00632-x

Mesa-Herrera F, Taoro-González L, Valdés-Baizabal C, Diaz M, Marín R. Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers. Int J Mol Sci. 2019;20(15):3810. Published 2019 Aug 4. DOI:10.3390/ijms20153810

Skinner AC, Steiner MJ, Chung AE, Perrin EM. Cholesterol curves to identify population norms by age and sex in healthy weight children. Clin Pediatr (Phila). 2012 Mar;51(3):233-7. DOI: 10.1177/0009922811430344. Epub 2011 Dec 8. PMID: 22157422; PMCID: PMC3368222.

Farjam M, Kheirandish M, Ghanbarnejad A, et al. Reference Interval for Non-HDL-Cholesterol, Remnant Cholesterol and Other Lipid Parameters in the Southern Iranian Population; Findings From Bandare Kong and Fasa Cohort Studies. Arch Iran Med. 2024;27(1):15-22. Published 2024 Jan 1. DOI:10.34172/aim.2024.03

Sizar O, Khare S, Patel P, et al. Statin Medications. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430940/

Vinagre CG, Freitas FR, de Mesquita CH, et al. Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects. Aging Dis. 2018;9(4):748-754. Published 2018 Aug 1. DOI:10.14336/AD.2017.1003

Simo OK, Berrougui H, Fulop T, Khalil A. The Susceptibi­lity to Diet-Induced Atherosclerosis Is Exacerbated with Aging in C57B1/6 Mice. Biomedicines. 2021;9(5):487. Published 2021 Apr 29. DOI:10.3390/biomedicines9050487

Published

2024-09-02

How to Cite

ZHURBA, O. O. (2024). CHOLESTEROL AS A CLINICAL AND LABORATORY MARKER OF METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF DIFFERENT AGE GROUPS. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (3), 64–70. https://doi.org/10.11603/2414-4533.2024.3.14925

Issue

Section

EXPERIENCE OF WORK